FinancialContent

Latest News about UK:GSK

Recent news which mentions UK:GSK

GSK first quarter profit dips to £1.49 billion but beat analyst forecasts
Tags UK:GSK
From MarketWatch
Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
Tickers BAC BBBY BK BLU
Tags PLUG BAC JNJ
From MarketWatch
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
Tickers BLU GSK
Tags CA:BLU UK:GSK GSK
From MarketWatch
GSK reports positive phase 3 data for UTI oral antibiotic
Tags UK:GSK
From MarketWatch
FTSE 100 hits fresh record above 8,000 on weak pound and renewed demand for energy stocks
Tickers BBEU SPX VGK
Tags UK:GSK UK:RIO UK:BP
From MarketWatch
GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses
Tickers GSK
Tags UK:GSK GSK
From MarketWatch
Moderna is the latest company to produce a promising RSV vaccine
Tickers JNJ MRNA PFE SPX
Tags JNJ SPX UK:GSK
From MarketWatch
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
Tickers CVAC GSK MRNA PFE
Tags UK:GSK CVAC PFE
From MarketWatch
Get ready for a ‘conundrum’ of a respiratory illness season
Tickers PFE
Tags UK:GSK PFE
From MarketWatch
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
Tickers GSK
Tags GSK UK:GSK
From MarketWatch
GSK to withdraw Blenrep’s U.S. marketing authorization after FDA request
Tags UK:GSK
From MarketWatch
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
Tickers GSK
Tags GSK UK:GSK FR:SAN
From MarketWatch
GSK spinoff Haleon lifts guidance as revenue rises on higher sales and volumes
Tickers GSK PFE
Tags GSK UK:HLN UK:GSK
From MarketWatch
GSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
Tickers GSK
Tags UK:HLN GSK UK:GSK
From MarketWatch
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
Tickers GSK
Tags UK:GSK GSK
From MarketWatch
GSK says U.S. FDA approves Boostrix for immunization during pregnancy
Tags UK:GSK
From MarketWatch
There’s a good bet to be made in this ‘un-investable’ country, says UBS
Tickers AAPL AMC AMD APE
Tags UK:HSBA BP TSLA
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Tickers ABBV AZN BMY LLY
Tags LLY UK:AZN CH:NOVN
From MarketWatch
Zantac lawsuit drop ‘not as significant as it appears’ for GSK stock, analysts say
Tickers GSK HLN PFE SNY
Tags UK:GSK HLN SNY
From MarketWatch
GSK defends Zantac ahead of trials that have cratered the stock
Tickers GSK HLN PFE SNY
Tags HLN UK:GSK SNY
From MarketWatch
GSK second quarter profit dips to $1.3 billion but raises outlook for rest of year
Tags UK:GSK
From MarketWatch
COVID-variant booster from Sanofi, GSK shows promising results
Tickers BNTX GSK MRNA PFE
Tags BNTX PFE MRNA
From MarketWatch
GSK to pay up to $3.3 billion for biopharma Affinivax
Tickers GSK
Tags UK:GSK GSK
From MarketWatch
GlaxoSmithKline earnings, revenue beat expectations
Tags UK:GSK
From MarketWatch
GlaxoSmithKline to buy Sierra Oncology for $1.9 billion
Tickers GSK SRRA
Tags GSK SRRA UK:GSK
From MarketWatch
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
Tickers BNTX GSK LLY MRK
Tags UK:GSK REGN BNTX
From MarketWatch
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
Tickers ADGI CVAC GSK
Tags GSK ADGI UK:GSK
From MarketWatch
CDC expected to loosen COVID face-mask advice later Friday, and Canada authorizes first plant-based vaccine
Tickers GSK
Tags UK:GSK GSK
From MarketWatch
WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths
Tickers GSK MRNA PFE SNY
Tags GSK FR:SAN MRNA
From MarketWatch
London stocks struggle after stronger-than-expected UK economic growth data
Tickers BCS GSK NWG UL
Tags NWG GBPUSD BX:TMBMKGB/10Y
From MarketWatch